Please wait...

Learn

Finding accredited CPD

Anti-mullerian hormone and use in General Practice

Description

Infertility rates affect up to 1 in 15 people in Australia. Managing this common presentation to GP clinics is often multifactorial, complicated and emotional. Many patients seek GP guidance to identify why they are experiencing fertility issues and what may be done. Anti-mullerian hormonal (AMH) testing is commonly requested, but is it accurate, does it help and how do you interpret the results?

Join Dr James Brown, IVF Specialist, as he shares insights into when and why to use AMH testing, how to interpret the results and how to share this with your patients.


Details

Learning Objectives:

  1. Review the role of Anti-Mullerian Hormone (AMH) testing in female fertility
  2. Discuss the testing limitations and when to use/avoid
  3. Discuss how to interpret AMH testing and educate patients on results/impact on fertility.

Disclaimer: Please note, once you click 'Register now' you will be leaving the AMA’s CPD Home website and entering a third-party education provider’s website. If you choose to register for this learning, you will need to provide some of your personal information directly to the third-party education provider. If you have any queries about how third-party education providers use, disclose or store your personal information you should consult their privacy policy.

Upon completion, your CPD activity record may take up to 4 weeks to be reflected on your CPD Home Dashboard.

Provided by


CPD Activity Details
Topic
General Practice and Primary Care, Women's Health
CAPE Aspects
_
Effective Year

Educational Activities (EA) - 0.30

Reviewing Performance (RP) - 1.0

Measuring Outcomes (MO) - 0.0

You have to log in to see the content of this module.

*Medical Board of Australia’s (MBA)’s revised Registration Standard: Continuing professional development (the Standard)